Evaluation of the biological effect of brahmi (Bacopa monnieri Linn) extract on the biodistribution of technetium-99m radiopharmaceuticals

Life Science Journal

Volumn 5, Issue 2, 2008, Pages 45-49

  de, Kakali ^a   Chandra, Susmita ^a   Misra, Mridula ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

99mTc CDM; 99mTc ECD; Bacopa monniera extract; Biodistribution

Indexed keywords

BACOPA MONNIERI; RATTUS;

EID: 57549093638     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 99mTc) in Wister rats. Cell Mol Biol 2003; 49: 501-7.
2. Bhattacharya SK, Bhattacharya A, Kumar A, Ghosal S. Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother Res 2000; 14: 174-9.
3. Braga ACS, Oliveira MBN, Feliciano GD, Reiniger IW, Oliveira JF, Silva CR, Bernardo-Filho M. The effect of drugs on the labeling of blood elements with technetium-99m. Curr Pharm Design 2000; 6: 1179-91.
4. 99mTc-DTPA in Balb/c mice. J Exp Clin Cancer Res 1998; 17: 313-6.
5. Chandra R. Nuclear Medicine Physics the Basics. 5th edition. New York, Willians and Wilkins. 1998.
6. Cheesman EH, Blanchette MA, Calabrese JC, Ganey MV, Maheu LJ, Morgan RA. Technetium-99m complexex of ester derivatized diamine-dithiol ligands for imaging brain perfusion. J Label Comd Radiopharm 1989; 26: 421-3.
7. Dire GF, Lima E, Gomes ML, Moreno S, Faria MVC, Jales RL, Catanho MTJA. Evaluation of the biological effects of a natural extract of Chayotte (Sechium edula): A molecular and cellular analysis. Pak J Nut 2003; 2: 249-53.
8. Early PJ, Sodee DB. Principles and Practice of Nuclear Medicine. Toronto: Mosby Year Book. 1996: 877.
9. Giles AR. Guidelines for the use of animals in biomedical research. Thromb Haemost 1987; 58: 1078-84.
10. Gomes ML, Braga ACS, Maltos DMM, Freitas RS, Bernardo-Filho M. Mitomycin-C effect on the biodistribution of the radiopharmaceutical technetium-99m-methylenediphosphonic acid in balb/c mice. Nucl Med Commun 1998; 19: 1177-9.
11. Gomes ML, Oliveira MN, Bernardo-Filho M. Drug interaction with radiopharmaceuticals: effect on the labeling of red blood cells with technetium-99m and on the bioavailability of radiopharmaceuticals. Braz Arch Biol Technol 2002; 45: 143-9.
12. Hung JC, Ponto JA, Hammes RJ. Radiopharmaceutical-related pitfalls and artifacts. Semin Nucl Med 1996; 26: 208-55.
13. Hladik III WB, Saha GB, Study KT. Therapeutic Applications of Radiopharmaceuticals, Essentials of Nuclear Medicine Science. London, Williams and Wilkins. 1987.
14. Hesslewood S, Leung E. Drug interactions with radiopharmaceuticals. Eur J Nucl Med 1994; 21: 348-56.
15. 99mTc-ECD). Nuclear Medicine & Biology 1998; 25:569-75.
16. Jyoti A, Sethi P, Sharma D. Bacopa monniera prevents from aluminium-neurotoxicity in the cerebral cortex of rat brain. J Ethnopharmacology 2007; 111: 56-62.
17. Jyoti A, Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. NeuroToxicology 2006; 27: 451-7.
18. Kung HF, Molnar M, Billings J, Wicks R, Blau M. Synthesis and biodistribution of neutral lipid soluble Tc-99m complexes that cross the blood brain barrier. J Nucl Med 1984; 25: 326-32.
19. Leveille J, Demonceau G, Roo MD, Rigo P, Taillefer R, Morgan RA, Kupranick MD, Walovitch RC. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans. J Nucl Med 1989; 30: 1902-10.
20. Mattos DMM, Gomes ML, Freitas RS, Moreno S, Nascimento ALR, Carvalho JJ, Bernardo-Filho M. Vincristine toxicity: the effect on the biodistribution of radiopharmaceutical and in the optical microscopy organs isolated from the treated animals. J Labeled Cpd Radiopharm 2001; 44: 477-9.
21. Mattos DM, Gomes ML, Freitas RS. A model to evaluate the biological effect of natural products vincristine action on the biodistribution of radiopharmaceutical in BALB/c female mice. J Appl Toxicol 1999; 19: 251-4.
22. Mattos DM, Gomes ML, Freitas RS. The effect of vincristine on the biodistribution of technetium-99m DTPA, GHA, and DMSA in BALB/c female mice. J Nucl Med Technol 2000; 28: 271-4.
23. Misra M, Das BK, Gambhir S, Mittal BR, Sewatkar AB, Ghosh S, Banerjee SN. Clinical evaluation of Tc-99m cystine: a new renal radiopharmaceutical. Clinical Nuclear Medicine 1994; 19: 314-20.
24. Moreno SRF, Carvalho JJ, Nascimento AL, Pereira M, Rocha EK, Dire G, Arnobio A. Bioavailability of the sodium pertechnate and morohometry of organs isolated from rats: study of ossible pharmacokinetic interactions of a ginkgo biloba extract. Braz Arc Biol and Tech 2005; 48: 73-8.
25. Moreno SRF, Silva ALC, Dire G, Honeycut H, Carvalho JJ, Nascimento AL. Effect of oral ingestion of an extract of the herb Uncaria tomentosa on the biodistribution of sodium pertechnetate in rats. Braz J Med Biol Res 2007; 40: 77-80.
26. Oliveira JF, Avila AS, Braga ACS, Oliveira MBN, Boasquevisque RL, Jales RLC, Cardoso VN, Bernardo-Filho M. Effect of extract of medicinal plants on the labeling of blood elements with technetium-99m and on the morphology of red blood cells: I-a study with Paullinia cupana. Fitoterapia 2002; 73: 305-12.
27. Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. Chronic effects of Bhahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology 2002; 27: 279-81.
28. Russo A, Borrelli F. Bacopa monniera, a reputed nootropic plant: an overview. Phytomedicine 2005; 12: 305-17.
29. Russo A, Izzo AA, Borrelli F, Renis M, Vanella A. Free radical scavenging capacity and protective effect of Bacopa monniera Linn on DNA damage. Phytother Res 2003; 17: 870-5.
30. Singh HK, Dhawan BN. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn (Brahmi). Indian J Pharmacol 1997; 29: 359-65.
31. Srivastava SC. Is there life after technetium: what is the potential for developing new broad-based radionuclides. Semin Nucl Med 1996; 26: 119-31.
32. Steinherz R, Tietze F, Gahil WA, Triche TJ, Chiang H, Andrea M, Schulman JD. Cystine accumulation and clearance by normal and cystinotic leukocytes exposed to cystine dimethyl ester. Proc Natl Acad Sci 1982; 79: 4446-50.
33. Vanlic-Razumenic N. Radiopharmaceutical complexes of technetium and tin: physicochemical and biochemical research. J Radioanal Nucl Chem 1999; 242: 235-40.
34. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, Oleary DH. Characterization of technetium 99m-LLECD for brain perfusion imaging. (Part I). Pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med 1989; 30: 1892-901.
35. http://www.anyvitamins.com/cystine-info.htm